BOLD SCHEDULE 13G/A: SEC filing

Tang Capital Management LLC and affiliated entities

Filed with the SEC on · accession 0001214659-26-014412

BOLD filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,840,635 shares, or 12.5%, of Boundless Bio, Inc. common stock as of September 30, 2026. The stock moved -2.8% by the first close after the filing.

Summary of the filing

Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,840,635 shares, or 12.5%, of Boundless Bio, Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

Key details

Shares beneficially owned by Tang Capital Management LLC$2.8M
Shares beneficially owned by Tang Capital Partners, LP$655K
Shares beneficially owned by Tang Capital Partners International, LP$888K
Shares beneficially owned by Tang Capital Partners III, Inc.$655K
Shares beneficially owned by Tang Capital Partners IV, Inc.$643K
IssuerBoundless Bio, Inc.
Filer / beneficial ownerTang Capital Management, LLC
Affiliated filer / beneficial ownerTang Capital Partners, LP
Affiliated filer / beneficial ownerTang Capital Partners International, LP
Affiliated filer / beneficial ownerTang Capital Partners III, Inc.
Affiliated filer / beneficial ownerTang Capital Partners IV, Inc.
Manager of tang capital management llc and ceo of tang capital partners iii and ivKevin Tang

How BOLD stock reacted

Close before

$2.50

Nov 13, 2026

First close after

-2.80%

$2.43

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BOLD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BOLD?

Click here

Frequently asked questions

What did BOLD file with the SEC on Nov 16, 2026?

BOLD filed a SCHEDULE 13G/A (SEC filing). Tang Capital Management LLC and affiliated entities filed an amended Schedule 13G reporting beneficial ownership of 2,840,635 shares, or 12.5%, of Boundless Bio, Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(c).

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did BOLD stock react to this filing?

BOLD closed at $2.50 before the filing and $2.43 on Nov 16, 2026 (-2.80%).

Other BOLD SEC filings

Get alerts when BOLD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days